The discovery of vascular endothelial-derived growth factor (VEGF) has revolutionized our
understanding of vasculogenesis and angiogenesis during development and physiological …

Diabetic retinopathy (DR) is the most common complication of diabetes mellitus (DM). It has
long been recognized as a microvascular disease. The diagnosis of DR relies on the …

Background To reduce treatment burden and optimise patient outcomes in diabetic macular
oedema, we present 1-year results from two phase 3 trials of faricimab, a novel angiopoietin …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …

Diabetes mellitus has profound effects on multiple organ systems; however, the loss of
vision caused by diabetic retinopathy might be one of the most impactful in a patient's life …

Diabetic retinopathy diagnostic assessment and treatment options have improved
dramatically since the 2002 American Diabetes Association Position Statement (1). These …

Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285
million people with diabetes mellitus worldwide, approximately one third have signs of DR …

Major advances in diagnostic technologies are offering unprecedented insight into the
condition of the retina and beyond ocular disease. Digital images providing millions of …

Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus and
is the leading cause of visual loss in the elderly. Hyperglycemia and altered metabolic …